Clinical Trial Update: Reduced vs Conventional Dosage Intensity-modulated Radiotherapy for Chemotherapy-sensitive Stage II-III Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing reduced versus conventional dosage intensity-modulated radiotherapy in chemotherapy-sensitive stage II-III nasopharyngeal carcinoma is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma, Radiotherapy | Phase 3 | Status: RECRUITING